Extent of therapeutic inertia across the world – a systematic review

Health-related quality of life

 

Professor Nicolucci presented interesting data on the health-related quality of life in DISCOVER patients.

 

Extent of therapeutic inertia across the world – a systematic review

DISCOVER study presented at ICPE 2018

 

Diversity of sites, physicians and patients in the DISCOVER study presented at ICPE 2018

 

DISCOVER at EASD 2018

Presenting DISCOVER activities at EASD 2018 in Berlin, Germany.

 

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 

Type 2 diabetes and real world evidence

 

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.

 

The DISCOVER study

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 
 

Type2 diabetes and real world evidence

Type 2 diabetes and real world evidence

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.